Corlanor — Class II drug recall D-0615-2026
Ongoing recall by Amgen, Inc., reported 2026-07-01, distributed nationwide. Presence of Foreign Substance.
| Recall number | D-0615-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amgen, Inc., Thousand Oaks, CA, United States |
| Recall initiated | 2026-06-04 |
| Classified | 2026-06-23 |
| Reported by FDA | 2026-07-01 |
| Distributed | Nationwide (US) |
| NDC | 55513-0800, 55513-0800-60, 55513-0800-99, 55513-0810, 55513-0810-60, 55513-0813, 55513-0813-01, 55513-0813-28 |
| Lot numbers | 1138203, 1142065, 1145151, 1145152, 1145153, 1148908, 1148909, 1162845, 1162846, 1166471, 1166472, 1166473, 1170615 |
| Expiration dates | 2026-07-31, 2027-02-28, 2027-05-31, 2027-11-30, 2028-05-31, 2028-08-31 |
Product
Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60
Reason for recall
Presence of Foreign Substance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0615-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.